Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Research|September 9, 2010
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patientsBelinda Palermo, Duilia Del Bello, Alessandra Sottini, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine modelEnrico Proietti, Laura Bracci, Simona Puzelli, et al.Cells|April 16, 2020
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis BlockadeAlessandra Rossi, Valeria Lucarini, Iole Macchia, et al.Cancer Immunology Research|April 7, 2018
Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem CellsLuciano Castiello, Paola Sestili, Giovanna Schiavoni, et al.Journal of Translational Medicine|May 3, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanomaCarmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, et al.International Journal of Cancer|October 8, 2008
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patientsPaola Nisticò, Imerio Capone, Belinda Palermo, et al.Frontiers in Oncology|March 27, 2020
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II StudyFrancesca Urbani, Virginia Ferraresi, Imerio Capone, et al.Nature Medicine|October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapyAntonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.Oncoimmunology|May 6, 2015
Consensus guidelines for the detection of immunogenic cell deathOliver Kepp, Laura Senovilla, Ilio Vitale, et al.Journal of Translational Medicine|December 16, 2011
Defining the critical hurdles in cancer immunotherapyBernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.Pageof 4